Mass Spec 2026:
September 16 - 18, 2026
Welcome to Mass Spec 2026! The focus of this Symposium is the practical application of mass spectrometry (MS) in the biotechnology industry. Mass spectrometry is a critical analytical technology used in the discovery, development, and commercialization of biopharmaceuticals. This Symposium provides an interactive forum to share experiences, insights, and novel developments between industry, academia, and regulatory agencies worldwide. The goals of the Symposium are to communicate best practices and innovative approaches for mass spectrometry applications in biopharma, as well as promote colleague networking and open discussions, thereby allowing attendees to advance their own projects more efficiently and confidently.
Mass Spec 2026 Program Partners
The scientific organizing committees gratefully acknowledge the following program partners for their generous support of Mass Spec 2026.
Strategic Diamond Program Partners | Strategic Platinum Program Partners | Strategic Gold Program Partner | Strategic Silver Program Partner | Silver Program Partner |
Amgen Inc. AstraZeneca Biogen Eli Lilly and Company F. Hoffmann-La Roche Ltd Genentech, a Member of the Roche Group | Gilead Sciences, Inc. Pfizer Inc. Sanofi | Bristol-Myers Squibb Company | Boehringer Ingelheim International GmbH | Johnson & Johnson |
Mass Spec 2026 Exhibitors
The scientific organizing committee gratefully acknowledges the following exhibitors for their generous support of Mass Spec 2026.
|
Exhibitor Diamond Program Partners
| Exhibitor Gold Program Partners | Exhibitors | Leading Media Partner |
Catalent, Inc.
SCIEX | BioAgilytix Labs Waters Corporation | Andson Biotech Inc. | International Pharmaceutical Quality |